---
audienceLevel: patient
cancerTypes:
- bladder
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Nadofaragene Firadenovec-vncg - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/nadofaragene-firadenovec-vncg
version: v1
---

# Nadofaragene Firadenovec-vncg - NCI

# Nadofaragene Firadenovec-vncg

Placeholder slot

(NA-doh-FAR-uh-jeen FIR-uh-DEH-noh-vek)

This page contains brief information about nadofaragene firadenovec-vncg
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Adstiladrin

FDA Approved

Yes

[FDA label information for this drug is available here.](https://www.fda.gov/media/164029/download)

## Use in Cancer

Nadofaragene firadenovec-vncg
is approved to treat:

- **[Non-muscle–invasive bladder cancer](/Common/PopUps/popDefinition.aspx?id=45122&version=Patient&language=English)** with [carcinoma in situ](/Common/PopUps/popDefinition.aspx?id=46488&version=Patient&language=English). It is used in adults whose cancer does not respond to treatment with [bacillus Calmette-Guérin](/Common/PopUps/popDefinition.aspx?id=44581&version=Patient&language=English) (BCG) and has a high risk of coming back.

Nadofaragene firadenovec-vncg
is also being studied in the treatment of other types of
cancer.

## More About Nadofaragene Firadenovec-vncg

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/573538) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Nadofaragene Firadenovec-vncg](https://medlineplus.gov/druginfo/meds/a623062.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Immune System Modulators](https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/immune-system-modulators)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Nadofaragene Firadenovec-vncg](https://www.cancer.gov/research/participate/clinical-trials/intervention/C71011) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
